Market Overview

Benzinga's Top Downgrades

Related ATU
Biotechs Among Stocks That Insiders Have Been Buying Lately
Benzinga's Top Upgrades
Related XYL
Benzinga's Top Upgrades
Xylem: A Safe Haven From Global Uncertainty

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

Nov 2015SunTrust Robinson HumphreyInitiates Coverage onBuy
Oct 2015JP MorganUpgradesUnderweightNeutral
Sep 2015BarclaysInitiates Coverage onEqual-weight

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ATU + ANTH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters